References
- International Nijmegen breakage syndrome study group. Nijmegen breakage syndrome. Arch Dis Child. 2000; 82(5): 400-406.
- Wegner RD, Chrzanowska K, Sperling K, Stumm M. Ataxia-telangiectasia variants (Nijmegen breakage syndrome) In: Ochs HD, Smith CIE, Puck JM, Eds. Immunodeficiency Disorders: A Molecular and Genetic Approach. Oxford, UK: Oxford University Press. 1999: 324-334.
- Carney Jp, Maser Rs, Olivares H, Davis EM, Le Beau M, Yates JR III, et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell. 1998; 93(3): 477-486.
- Matsuura S, Tauchi H, Nakamura A, Kondo N, Sakamoto S, Endo S, et al. Positional cloning of the gene for Nijmegen breakage syndrome. Nat Genet. 1998; 19(2): 179-181.
- Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 1998; 93(3): 467-447.
- Saar K, Chrzanowska KH, Stumm M, Jung M, Nurnberg G, Wienker TF, et al. The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1 cM interval on chromosome 8q21. Am J Hum Genet. 1997; 60(3): 605-610.
- Cerosaletti KM, Lange E, Stringham HM, Weemaes CM, smeets D, Sölder B, et al. Fine localization of the Nijmegen breakage syndrome gene to 8q21: Evidence for a common founder haplotype. Am J Hum Genet. 1998; 63(1): 125-134.
- D’Amours D, Jackson SR. The Mre11 complex at the crossroads of DNA repair and checkpoint signaling. Nat Rev Mol Cell Biol. 2002; 3(5): 317-327.
- Varon R, Seemanowa E, Chrzanowska K, Hnateyko O, Piekutowska-Abramczuk D, Krajewska-Walasek M, et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet. 2008; 8(11): 900-902.
- Chrzanowska K, Piekutowska-Abramczuk D, Popowska E, Gladkowska-Dura M, Maldyk J, Syczewska M, et al. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int J Cancer. 2006; 116(5): 1269-1274.
- di Masi A, Antoccia A. NBS1 Heterozygosity and cancer risk. Curr Genomics. 2008; 9(4): 275-281.
- Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, et al. Non-Hodgkin’s lymphoma of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - A report of Berlin-Frank-furt-Münster Group. J Clin Oncol 1995; 13(2): 359-372.
- Dembowska Baginska B, Perek D, Brozyna A, Wakulinska A, Olczak Kowalczyk D, Gladkowska Dura M, et al. Non Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS). Pediatr Blood Cancer. 2009; 52(2): 186-190.
- Gregorek H, Chrzanovska KH, Michalkiewitz J, Syczewska M, Madalinski K. Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: An 8-year follow-up study in a single centre. Clin Exp Immunol. 2002; 130(2): 319-324.